Lipoflex Peri

Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonine, the active ingredients in Lipoflex Peri, are an amino acid solution presented as an intravenous formulation for parenteral use. It supports peri‑operative protein needs in adult surgical patients.

GNH USA supplies Lipoflex Peri as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Lipoflex Peri is used as a parenteral amino acid supplement to address protein and nitrogen deficits in clinical settings. - Peri‑operative nutrition: helps maintain nitrogen balance and supports wound healing during and after surgery. - Total parenteral nutrition (TPN): provides essential amino acids when oral intake is not possible. - Catabolic states: supplies substrates for protein synthesis in patients with severe trauma or burns.

Lipoflex Peri may be associated with infusion‑related reactions and metabolic changes.

Common Side Effects: - Phlebitis at the infusion site: inflammation of the vein. - Hyperglycemia: elevated blood glucose levels, especially in diabetic patients. - Electrolyte disturbances: mild shifts in potassium or calcium. - Mild nausea or vomiting during infusion. - Transient fever or chills.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Metabolic acidosis: significant acid‑base imbalance. - Hyperosmolarity: excessive osmolar load leading to renal stress. - Severe electrolyte imbalance: dangerous potassium or calcium shifts. - Bacterial contamination: rare but possible infection risk if aseptic technique fails.

When using Lipoflex Peri, clinicians should consider patient‑specific factors and monitor for adverse events. - Renal function: assess creatinine clearance before infusion. - Hepatic impairment: adjust dosing in severe liver disease. - Diabetes mellitus: monitor blood glucose closely. - Fluid balance: avoid overload in patients with heart failure. - Compatibility: do not mix with calcium‑containing solutions unless verified. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Amino acid solutions can interact with other intravenous therapies, altering electrolyte or osmolar balance.

Major Interactions (Avoid): - Concurrent high‑potassium IV fluids: risk of hyperkalemia. - Calcium‑containing solutions mixed directly: precipitation risk. - Certain antibiotics (e.g., aminoglycosides) when co‑infused: may reduce efficacy.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate electrolyte shifts. - Insulin therapy: increased risk of hypoglycemia if glucose not adjusted. - Anticoagulants: monitor coagulation parameters if large volumes are infused.